Guidelines are designed to diagnose HIV early and identify people at high risk of acquiring HIV to enable referral for treatment and preventive services.
Results show no difference in risk of stroke, myocardial infarction or pulmonary embolism with Pfizer monovalent versus Pfizer bivalent COVID-19 boosters.